$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Global License

Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020
[Lowest Price Guaranteed: $5,650]

Published by MarketsandMarkets: 24 Jul 2015 | 41767 | In Stock

Introduction

The report segments the breast biopsy market on the basis of products, types, guidance, and regions. On basis of products, the breast biopsy market is classified into biopsy needles, guidance systems, biopsy tables, localization wires, and others (markers, punches, sutures). The breast biopsy needles market is expected to account for largest share of the global breast biopsy needles market. The growth of the segment can be attributed to the increasing demand for needle biopsy.

Based on types, the market is categorized into needle and open surgical breast biopsy market. The needle breast biopsy market is subsegmented into core needle biopsy (CNB), fine needle aspiration biopsy (FNAB), and vacuum-assisted biopsy (VAB). Among these, the vacuum-assisted biopsy segment is expected to be fastest-growing segment. Growth can be attributed to the growing demand for less invasive breast biopsy procedures worldwide. The open surgical breast biopsy market is subsegmented into excisional and incisional breast biopsy.

Acquisition was the major strategy adopted by industry players. Emerging and immature markets such as Brazil, Argentina, Mexico, China, and India are lucrative markets for breast biopsy market, owing to the increasing incidences of breast cancer cases in these regions.

This research report focuses on qualitative data, market size, and the growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and the initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the breast biopsy market and their product portfolios, developments, and strategies adopted to maintain and increase their market shares. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the breast biopsy market. The report analyzes the breast biopsy market by product, type, guidance, and region.

• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the breast biopsy market.

• Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the breast biopsy market.

• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various products across geographies

• Market Diversification: Exhaustive information on new products and services, untapped geographies, recent developments, and investments in the breast biopsy market

Table of Contents
for Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020

  • TABLE OF CONTENTS

    1 INTRODUCTION 15

    1.1 OBJECTIVES OF THE STUDY 15

    1.2 MARKET DEFINITION 15

    1.3 MARKET SCOPE 15

    1.3.1 MARKETS COVERED 15

    1.3.2 YEARS CONSIDERED FOR THE STUDY 16

    1.4 CURRENCY 17

    1.5 LIMITATIONS 17

    1.6 STAKEHOLDERS 17

    2 RESEARCH METHODOLOGY 18

    2.1 MARKET SIZE ESTIMATION 19

    2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 21

    2.2.1 KEY DATA FROM SECONDARY SOURCES 22

    2.2.2 KEY DATA FROM PRIMARY SOURCES 23

    2.2.2.1 Key industry insights 24

    2.2.3 ASSUMPTIONS FOR THE STUDY 24

    3 EXECUTIVE SUMMARY 25

    4 PREMIUM INSIGHTS 29

    4.1 BREAST BIOPSY MARKET TO GROW AT A STEADY RATE 29

    4.2 BREAST BIOPSY MARKET, BY GUIDANCE SYSTEM 30

    4.3 BREAST BIOPSY MARKET, BY REGION 31

    4.4 BREAST BIOPSY MARKET, BY PRODUCT 31

    4.5 NEEDLE BREAST BIOPSY MARKET 32

    4.6 LIFECYCLE ANALYSIS, BY REGION 32

    5 MARKET OVERVIEW 33

    5.1 INTRODUCTION 34

    5.2 MARKET SEGMENTATION 34

    5.3 MARKET DYNAMICS 35

    5.3.1 DRIVERS 36

    5.3.1.1 Increasing incidence of breast cancer 36

    5.3.1.2 Increasing number of breast cancer screening programs 36

    5.3.1.3 New reimbursement guidelines for breast biopsy procedures in the U.S. 37

    5.3.1.4 Increasing demand for minimally invasive surgeries 37

    5.3.2 RESTRAINTS 38

    5.3.2.1 Regulatory issues 38

    5.3.2.2 Infection risks related to breast biopsy procedures 38

    5.3.3 OPPORTUNITIES 38

    5.3.3.1 Growth opportunities in emerging countries 38

    5.3.4 CURRENT TRENDS 39

    5.3.4.1 Emergence of liquid biopsy 39

    6 BREAST BIOPSY MARKET, BY PRODUCT 40

    6.1 INTRODUCTION 41

    6.2 BIOPSY NEEDLES 42

    6.3 GUIDANCE SYSTEMS 43

    6.4 BIOPSY TABLES 44

    6.5 LOCALIZATION WIRES 45

    6.6 OTHERS 46

    7 BREAST BIOPSY MARKET, BY TYPE 47

    7.1 INTRODUCTION 48

    7.2 NEEDLE BREAST BIOPSY 49

    7.2.1 CORE-NEEDLE BIOPSY (CNB) 51

    7.2.2 FINE-NEEDLE ASPIRATION BIOPSY (FNAB) 53

    7.2.3 VACUUM-ASSISTED BIOPSY (VAB) 55

    7.3 OPEN SURGICAL BREAST BIOPSY 58

    7.3.1 EXCISIONAL BREAST BIOPSY 60

    7.3.2 INCISIONAL BREAST BIOPSY 60

    8 GLOBAL BREAST BIOPSY MARKET, BY GUIDANCE 61

    8.1 INTRODUCTION 62

    8.2 MAMMOGRAPHY-GUIDED STEREOTACTIC BREAST BIOPSY 63

    8.3 ULTRASOUND-GUIDED BREAST BIOPSY 65

    8.4 MRI-GUIDED BREAST BIOPSY 67

    8.5 OTHER GUIDANCE TECHNIQUES 69

    9 BREAST BIOPSY MARKET, BY REGION 71

    9.1 INTRODUCTION 72

    9.2 NORTH AMERICA 74

    9.2.1 U.S. 80

    9.2.2 CANADA 82

    9.3 EUROPE 83

    9.4 ASIA-PACIFIC (APAC) 87

    9.4.1 CHINA 92

    9.4.2 INDIA 94

    9.4.3 REST OF ASIA-PACIFIC (ROAPAC) 95

    9.5 REST OF THE WORLD (ROW) 96

    10 COMPETITIVE LANDSCAPE 100

    10.1 OVERVIEW 101

    10.2 MARKET SHARE ANALYSIS 102

    10.3 COMPETITIVE SITUATION AND TRENDS 103

    10.3.1 NEW PRODUCT LAUNCHES AND APPROVALS 103

    10.3.2 ACQUISITIONS 104

    10.3.3 EXPANSION 105

    10.3.4 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 105

    10.3.5 OTHER DEVELOPMENTS 106

    11 COMPANY PROFILES 107

    11.1 INTRODUCTION 107

    11.2 BECTON, DICKINSON AND COMPANY 108

    11.3 C.R. BARD, INC. 110

    11.4 DEVICOR MEDICAL PRODUCTS INC. 112

    11.5 HOLOGIC INC. 115

    11.6 ARGON MEDICAL DEVICES 118

    11.7 COOK MEDICAL INCORPORATED 120

    11.8 ENCAPSULE MEDICAL DEVICES LLC 122

    11.9 ETHICON ENDO SURGERY (JOHNSON AND JOHNSON) 123

    11.10 GALINI SRL 125

    11.11 INTACT MEDICAL CORPORATION 126

    *Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

    12 APPENDIX 127

    12.1 INSIGHTS OF INDUSTRY EXPERTS 127

    12.2 DISCUSSION GUIDE 128

    12.3 OTHER DEVELOPMENTS 130

    12.3.1 DEVICOR MEDICAL PRODUCTS INC. 130

    12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 130

    12.5 AVAILABLE CUSTOMIZATIONS 132

    12.6 RELATED REPORTS 133

List Of Tables
in Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020

LIST OF TABLES


TABLE 1 GROWING INCIDENCE OF BREAST CANCER TO DRIVE MARKET GROWTH 37

TABLE 2 INFECTION RISKS RELATED TO BREAST BIOPSY PROCEDURES TO RESTRAIN MARKET GROWTH 38

TABLE 3 EMERGING COUNTRIES TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES 39

TABLE 4 BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 41

TABLE 5 BREAST BIOPSY NEEDLES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 42

TABLE 6 BREAST BIOPSY GUIDANCE SYSTEMS MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 43

TABLE 7 BREAST BIOPSY TABLES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 44

TABLE 8 LOCALIZATION WIRES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 45

TABLE 9 OTHER BREAST BIOPSY PRODUCTS MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 46

TABLE 10 BREAST BIOPSY MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 48

TABLE 11 NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 49

TABLE 12 NEEDLE BREAST BIOPSY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 50

TABLE 13 NORTH AMERICA: NEEDLE BREAST BIOPSY MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 51

TABLE 14 ASIA-PACIFIC: NEEDLE BREAST BIOPSY MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 51

TABLE 15 CORE-NEEDLE BIOPSY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 52

TABLE 16 NORTH AMERICA: CORE-NEEDLE BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 53

TABLE 17 ASIA-PACIFIC: CORE-NEEDLE BREAST BIOPSY MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 53

TABLE 18 FINE-NEEDLE ASPIRATION BREAST BIOPSY MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 54

TABLE 19 NORTH AMERICA: FINE-NEEDLE ASPIRATION BREAST BIOPSY MARKET SIZE,

BY COUNTRY, 2013–2020 (USD MILLION) 55

TABLE 20 ASIA-PACIFIC: FINE-NEEDLE BREAST BIOPSY MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 55

TABLE 21 VACUUM-ASSISTED BREAST BIOPSY MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 56

TABLE 22 NORTH AMERICA: VACUUM-ASSISTED BREAST BIOPSY MARKET SIZE,

BY COUNTRY, 2013–2020 (USD MILLION) 57

TABLE 23 ASIA-PACIFIC: VACUUM-ASSISTED BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 57

TABLE 24 OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 58

TABLE 25 OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 59

TABLE 26 EXCISIONAL BREAST BIOPSY MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 60

TABLE 27 INCISIONAL BREAST BIOPSY MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 60

TABLE 28 BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013–2020 (USD MILLION) 62

TABLE 29 MAMMOGRAPHY GUIDANCE MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 64

TABLE 30 NORTH AMERICA: MAMMOGRAPHY GUIDANCE MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 64

TABLE 31 ASIA-PACIFIC: MAMMOGRAPHY GUIDANCE MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 64

TABLE 32 ULTRASOUND GUIDANCE MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 66

TABLE 33 NORTH AMERICA: ULTRASOUND GUIDANCE MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 66

TABLE 34 ASIA-PACIFIC: ULTRASOUND GUIDANCE MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 66

TABLE 35 MRI GUIDANCE MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 67

TABLE 36 NORTH AMERICA: MRI GUIDANCE MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 68

TABLE 37 ASIA-PACIFIC: MRI GUIDANCE MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 68

TABLE 38 OTHER GUIDANCE TECHNIQUES MARKET SIZE, BY REGION,

2013–2020 (USD MILLION) 69

TABLE 39 NORTH AMERICA: OTHER GUIDANCE TECHNIQUES MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 70

TABLE 40 ASIA-PACIFIC: OTHER GUIDANCE TECHNIQUES MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 70

TABLE 41 BREAST BIOPSY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 73

TABLE 42 NORTH AMERICA: BREAST BIOPSY MARKET SIZE, BY COUNTRY,

2013–2020 (USD MILLION) 76

TABLE 43 NORTH AMERICA: BREAST BIOPSY MARKET SIZE, BY GUIDANCE,

2013–2020 (USD MILLION) 77

TABLE 44 NORTH AMERICA: BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 78

TABLE 45 NORTH AMERICA: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 78

TABLE 46 NORTH AMERICA: OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 79

TABLE 47 NORTH AMERICA: BREAST BIOPSY MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 80

TABLE 48 U.S.: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013–2020 (USD MILLION) 81

TABLE 49 U.S.: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 81

TABLE 50 CANADA: BREAST BIOPSY MARKET SIZE, BY GUIDANCE,

2013–2020 (USD MILLION) 82

TABLE 51 CANADA: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 82

TABLE 52 EUROPE: BREAST BIOPSY MARKET SIZE, BY GUIDANCE,

2013–2020 (USD MILLION) 83

TABLE 53 EUROPE: BREAST BIOPSY MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 84

TABLE 54 EUROPE: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 85

TABLE 55 EUROPE: OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 85

TABLE 56 EUROPE: BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 86

TABLE 57 ASIA-PACIFIC: BREAST BIOPSY MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 88

TABLE 58 ASIA-PACIFIC: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 89

TABLE 59 ASIA-PACIFIC: OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 90

TABLE 60 ASIA-PACIFIC: BREAST BIOPSY MARKET SIZE, BY GUIDANCE,

2013–2020 (USD MILLION) 91

TABLE 61 ASIA-PACIFIC: BREAST BIOPSY MARKET SIZE, BY PRODUCT,

2013–2020 (USD MILLION) 92

TABLE 62 CHINA: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013–2020 (USD MILLION) 93

TABLE 63 CHINA: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 94

TABLE 64 INDIA: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013–2020 (USD MILLION) 95

TABLE 65 INDIA: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 95

TABLE 66 ROW: BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2013–2020 (USD MILLION) 97

TABLE 67 ROW: BREAST BIOPSY MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 98

TABLE 68 ROW: NEEDLE BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 98

TABLE 69 ROW : OPEN SURGICAL BREAST BIOPSY MARKET SIZE, BY TYPE,

2013–2020 (USD MILLION) 98

TABLE 70 ROW: BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 99

TABLE 71 NEW PRODUCT LAUNCHES AND APPROVALS, 2013–2015 103

TABLE 72 ACQUISITIONS, 2013-2015 104

TABLE 73 EXPANSIONS, 2013-2015 105

TABLE 74 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2015 105

TABLE 75 OTHER DEVELOPMENTS, 2012–2015 106

List Of Figures, Charts and Diagrams
in Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020

LIST OF FIGURES


FIGURE 1 RESEARCH DESIGN: BREAST BIOPSY MARKET 18

FIGURE 2 MARKET SIZE ESTIMATION 20

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION 20

FIGURE 4 DATA TRIANGULATION METHODOLOGY 21

FIGURE 5 NEEDLE BREAST BIOPSY MARKET SNAPSHOT (2015 VS. 2020): VACUUM-ASSISTED BREAST BIOPSIES EXPECTED TO SHOW FASTEST GROWTH 26

FIGURE 6 MAMMOGRAPHY SEGMENT IS EXPECTED TO DOMINATE BREAST BIOPSY GUIDANCE SYSTEMS MARKET IN 2015 26

FIGURE 7 ASIA-PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 27

FIGURE 8 BREAST BIOPSY GUIDANCE SYSTEMS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR 28

FIGURE 9 INCREASING INCIDENCES OF BREAST CANCER AND AWARENESS PROGRAMS TO DRIVE MARKET GROWTH 29

FIGURE 10 MAMMOGRAPHY SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE 30

FIGURE 11 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 31

FIGURE 12 BREAST BIOPSY GUIDANCE SYSTEMS SEGMENT EXPECTED TO BE THE FASTEST-GROWING MARKET 31

FIGURE 13 VACUUM-ASSISTED BIOPSY EXPECTED TO SHOW HIGHEST GROWTH 32

FIGURE 14 ASIA-PACIFIC MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 32

FIGURE 15 BREAST BIOPSY MARKET SEGMENTATION 34

FIGURE 16 BREAST BIOPSY MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES 35

FIGURE 17 BREAST CANCER: GLOBAL INCIDENCE AND MORTALITY AMONG WOMEN 36

FIGURE 18 NEEDLES PRODUCT SEGMENT TO DOMINATE BREAST PRODUCT MARKET IN 2015 41

FIGURE 19 APAC IS EXPECTED TO BE THE FASTEST-GROWING REGION IN THE BIOPSY NEEDLES MARKET (2015-2020) 42

FIGURE 20 NORTH AMERICA IS EXPECTED TO DOMINATE THE GUIDANCE SYSTEMS MARKET (2015) 43

FIGURE 21 EUROPE IS EXPECTED TO BE THE SECOND-LARGEST SEGMENT OF THE BIOPSY TABLES MARKET 44

FIGURE 22 EUROPE IS EXPECTED TO BE THE SECOND LARGEST SEGMENT OF THE LOCALIZATION WIRES MARKET 45

FIGURE 23 APAC MARKET FOR OTHER PRODUCTS EXPECTED TO SHOW FASTEST GROWTH 46

FIGURE 24 NEEDLE BREAST BIOPSY IS EXPECTED TO DOMINATE THE BREAST BIOPSY TYPE MARKET IN 2015 48

FIGURE 25 CORE-NEEDLE BIOPSY IS EXPECTED TO DOMINATE THE NEEDLE BREAST BIOPSY MARKET IN 2015 49

FIGURE 26 NORTH AMERICA EXPECTED TO DOMINATE THE NEEDLE BREAST BIOPSY MARKET IN 2015 50

FIGURE 27 ASIA-PACIFIC EXPECTED TO BE THE FASTEST-GROWING SEGMENT OF THE CORE-NEEDLE BIOPSY MARKET 52

FIGURE 28 NORTH AMERICA IS EXPECTED TO DOMINATE THE FINE-NEEDLE ASPIRATION BIOPSY MARKET IN 2015 54

FIGURE 29 ASIA-PACIFIC EXPECTED TO BE THE FASTEST-GROWING SEGMENT OF THE VACUUM-ASSISTED BIOPSY MARKET (2015- 2020) 56

FIGURE 30 EXCISIONAL BREAST BIOPSY EXPECTED TO BE THE FASTEST-GROWING SEGMENT IN THE OPEN SURGICAL BIOPSY MARKET (2015-2020) 58

FIGURE 31 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE OPEN SURGICAL BREAST BIOPSY MARKET 59

FIGURE 32 MAMMOGRAPHY IS EXPECTED TO DOMINATE THE BREAST BIOPSY GUIDANCE MARKET IN 2015 62

FIGURE 33 MAMMOGRAPHY GUIDANCE MARKET TO WITNESS THE HIGHEST GROWTH IN THE ASIA-PACIFIC REGION 63

FIGURE 34 NORTH AMERICA IS EXPECTED TO DOMINATE THE ULTRASOUND GUIDANCE MARKET IN 2015 65

FIGURE 35 ASIA-PACIFIC IS EXPECTED TO BE THE FASTEST-GROWING MARKET FOR MRI GUIDANCE 67

FIGURE 36 NORTH AMERICA IS EXPECTED TO DOMINATE THE OTHER GUIDANCE TECHNIQUES MARKET IN 2015 69

FIGURE 37 GEOGRAPHIC SNAPSHOT (2015): ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 72

FIGURE 38 ASIA-PACIFIC: AN ATTRACTIVE DESTINATION FOR ALL PRODUCT CATEGORIES 73

FIGURE 39 NORTH AMERICA IS EXPECTED TO DOMINATE THE BREAST BIOPSY MARKET (2015) 74

FIGURE 40 NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE IN THE BREAST BIOPSY MARKET (2015) 75

FIGURE 41 ULTRASOUND SEGMENT TO WITNESS HIGHEST GROWTH IN THE NORTH AMERICAN BREAST BIOPSY MARKET (2015-2020) 76

FIGURE 42 NEEDLE BREAST BIOPSY EXPECTED TO BE LARGEST AND FASTEST-GROWING SEGMENT IN THE BREAST BIOPSY MARKET IN NORTH AMERICA (2015-2020) 77

FIGURE 43 CORE-NEEDLE BIOPSY SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN THE NORTH AMERICAN NEEDLE BREAST BIOPSY MARKET (2015) 78

FIGURE 44 NEEDLES EXPECTED TO COMMAND THE LARGEST SHARE IN THE BREAST BIOPSY PRODUCTS MARKET IN NORTH AMERICA (2015) 79

FIGURE 45 NEEDLE BREAST BIOPSY TO COMMAND THE LARGEST SHARE IN THE BREAST BIOPSY MARKET IN EUROPE (2015) 84

FIGURE 46 VACUUM-ASSISTED BIOPSY EXPECTED TO BE FASTEST-GROWING SEGMENT IN IN THE EUROPEAN NEEDLE BIOPSY MARKET (2015-2020) 85

FIGURE 47 GUIDANCE SYSTEMS EXPECTED TO BE FASTEST-GROWING SEGMENT IN THE BREAST BIOPSY PRODUCTS MARKET IN EUROPE (2015-2020) 86

FIGURE 48 ASIA-PACIFIC EXPECTED TO BE FASTEST-GROWING SEGMENT IN THE GLOBAL BREAST BIOPSY MARKET (2015-2020) 87

FIGURE 49 NEEDLE BREAST BIOPSY SEGMENT TO GROW AT THE HIGHER CAGR IN THE FORECAST PERIOD 88

FIGURE 50 CORE-NEEDLE BIOPSY TO DOMINATE THE NEEDLE BREAST BIOPSY MARKET IN APAC (2015) 89

FIGURE 51 MAMMOGRAPHY TO DOMINATE THE APAC NEEDLE BREAST BIOPSY MARKET (2015) 90

FIGURE 52 GUIDANCE SYSTEMS TO BE THE FASTEST-GROWING SEGMENT IN THE APAC BREAST BIOPSY PRODUCTS MARKET (2015-2020) 91

FIGURE 53 ULTRASOUND TO BE THE FASTEST-GROWING SEGMENT IN THE MARKET IN CHINA (2015-2020) 93

FIGURE 54 MAMMOGRAPHY SEGMENT TO DOMINATE THE BREAST BIOPSY MARKET IN INDIA (2015) 94

FIGURE 55 MAMMOGRAPHY SEGMENT EXPECTED TO DOMINATE THE ROW BREAST BIOPSY MARKET (2015) 96

FIGURE 56 NEEDLE BREAST BIOPSY SEGMENT TO DOMINATE THE ROW BREAST BIOPSY MARKET (2015) 97

FIGURE 57 NEEDLES SEGMENT IS EXPECTED TO DOMINATE THE ROW BREAST BIOPSY PRODUCTS MARKET (2015) 99

FIGURE 58 COMPANIES ADOPTED NEW PRODUCT LAUNCHES AND APPROVALS AS THEIR KEY GROWTH STRATEGY (2012 – 2015) 101

FIGURE 59 GLOBAL BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2014 102

FIGURE 60 GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS 107

FIGURE 61 C.R. BARD, INC.: COMPANY SNAPSHOT 110

FIGURE 62 ETHICON ENDO SURGERY (JOHNSON AND JOHNSON): COMPANY SNAPSHOT 123

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

41767 | MD 3615

Number of Pages

134

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Breast Cancer Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical ...
29 Jun 2016 by Global Data USD $2,500 More Info
Breast Cancer: KOL Insight
IntroductionTargeted therapies deliver on promise to transform breast cancer treatmentTargeted thera...
01 May 2016 by FirstWord Pharma USD $7,900 More Info
Breast Cancer: Update Bulletin [March 2016]
IntroductionIn this update KOLs reflect on the promising Phase Ib data for Roche’s monoclonal antibo...
01 Mar 2016 by FirstWord Pharma USD $995 More Info
Physician Views: Evaluating the launch of Pfizer's Ibrance for breast cancer
ScopeApproved by the FDA in February on the strength of impressive Phase II data from the PALOMA-1 s...
01 Jul 2015 by FirstWord Pharma USD $695 More Info
Physician Views: Have expectations been reset for Puma Biotechnology's neratinib in HER2+ breast cancer?
Scope Investors appear to be resetting their expectations for Puma Biotechnology's experimental HER2...
01 May 2015 by FirstWord Pharma USD $695 More Info
Breast Cancer: KOL Insight
IntroductionHow will breast cancer be treated in the years ahead – and what targeted therapies repre...
01 May 2015 by FirstWord Pharma USD $7,900 More Info
Physician Views: When and where do oncologists see palbociclib fitting into the ER+, HER2- breast cancer landscape?
Scope Analysts believe palbociclib is likely headed for an accelerated approval to treat a subset of...
28 Aug 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Is the HER2-positive breast cancer extended adjuvant opportunity big enough to support neratinib's blockbuster forecasts?
Scope Top-line data from the ExteNET study – which were released earlier this week – appear to estab...
28 Jul 2014 by FirstWord Pharma USD $695 More Info
Breast Cancer: New targeted therapies transform treatment - KOL Insight
IntroductionThe introduction of targeted therapies revolutionised the breast cancer market, widening...
10 Feb 2014 by FirstWord Pharma USD $7,900 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...